Rosemary Scricca
About Rosemary Scricca
Rosemary Scricca is the Senior Central Monitoring Lead for Risk Based Monitoring at Bristol-Myers Squibb in New Jersey, with a background in Nursing from the University of Connecticut.
Company
Rosemary Scricca is currently employed at Bristol-Myers Squibb, a well-known global biopharmaceutical company. She serves as the Senior Central Monitoring Lead, Risk Based Monitoring. The company, based in New Jersey, focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Rosemary Scricca holds the title of Senior Central Monitoring Lead, Risk Based Monitoring. In this role, she is responsible for overseeing risk-based monitoring strategies, which are crucial in ensuring the integrity and safety of clinical trials and drug development processes.
Education and Expertise
Rosemary Scricca obtained her Bachelor's degree in Nursing from the University of Connecticut, where she studied from 1976 to 1982. Her education in nursing provides a solid foundation for her expertise in clinical monitoring. Specializing in Risk Based Monitoring, she applies her knowledge to critical functions within the pharmaceutical industry's clinical trials.
Background
With over three decades of experience at Bristol-Myers Squibb, Rosemary Scricca began her career at the company in 1989. Her long tenure with the firm highlights her extensive experience and deep understanding of the clinical monitoring and pharmaceutical industries. With a background in nursing, she leverages her clinical knowledge to excel in her current role.
Achievements
Rosemary Scricca's longstanding career at Bristol-Myers Squibb since 1989 is an achievement that underscores her dedication and expertise. Her role as Senior Central Monitoring Lead in Risk Based Monitoring signifies her important contributions to ensuring the success and safety of clinical trials, essential for drug development.